Log in

Relevant bibliographies by topics / Psychopharmacology / Journal articles

To see the other types of publications on this topic, follow the link: Psychopharmacology.

Journal articles on the topic 'Psychopharmacology'

Author: Grafiati

Published: 4 June 2021

Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Psychopharmacology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Birnbaum, Robert J. "Neuroscience and Psychopharmacology into the Next Millennium." CNS Spectrums 4, no. 7 (July 1999): 36–52. http://dx.doi.org/10.1017/s1092852900012001.

Full text

Abstract:

AbstractThe end of the millennium provides an opportunity to review some of the common practices that were present in psychopharmacology during the 20th century. The author focuses on two approaches that have dominated research and guided the clinical application of psychopharmacologic therapeutics: the unitary clinically-based and single-lesion perspectives. The author expands upon these older formulations of neuropsychiatric disease pathogenesis and describes how the approach to psychopharmacologic research and therapeutics has changed in light of advances in the basic neurosciences. Relevant recent advances in the basic neurosciences that shed light on the pathophysiology of neuropsychiatric disease states and that guide psychopharmacologic practices are described. The use of atypical antipsychotic agents to treat schizophrenia is given as one example of the clinical applications of the approach to psychopharmacology in the next century.

APA, Harvard, Vancouver, ISO, and other styles

2

Spies, M., and S. Kasper. "A European psychopharmacology curriculum: The young psychiatrist's point of view." European Psychiatry 33, S1 (March 2016): S63. http://dx.doi.org/10.1016/j.eurpsy.2016.01.956.

Full text

Abstract:

It goes without saying that psychopharmacologic treatment requires extensive knowledge of topics ranging from pharmacodynamics and efficacy, to pharmacokinetics, side-effects, and toxicity. Knowledge should be supplemented with experience regarding applicability in a clinical setting. It is well accepted that comprehensive psychopharmacologic education is essential to convey necessary knowledge and adequately prepare trainees for independent practice [1]. Currently, a psychopharmacologic curriculum, under the umbrella of the European Psychiatric Association, is in preparation in order to emphasize the importance of psychopharmacologic education in the context of psychiatric training and to foster standardization within the European Union. The aim of this presentation is to discuss psychopharmacologic education and prerequisites for an effective curriculum from the trainee's point of view. We will address challenges facing psychiatric trainees [2] and review existing curricula as well as literature in which they are evaluated. Based on evaluation of the model curriculum by the American Society of Clinical Psychopharmacology, one of the most broadly used psychopharmacologic curricula, it has been emphasized that an effective curriculum should be more than a list of topics. It should also convey pedagogic strategies with a focus on up-to-date technology, and provide a process through which teacher and trainee progress can be assessed [3,4]. Reflection on currently available curricula should aid in the development of an effective and timely EU-wide psychopharmacologic curriculum.Disclosure of interestThe authors have not supplied their declaration of competing interest.

APA, Harvard, Vancouver, ISO, and other styles

3

Zisook, Sidney. "Psychopharmacology." Journal of Clinical Psychiatry 59, no. 4 (April 15, 1998): 201. http://dx.doi.org/10.4088/jcp.v59n0410.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Rothschild, Anthony J. "Psychopharmacology." Journal of Clinical Psychopharmacology 42, no. 1 (January 2022): 1–2. http://dx.doi.org/10.1097/jcp.0000000000001518.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Cameron, Oliver G. "Psychopharmacology." Psychosomatic Medicine 61, no. 5 (September 1999): 585–90. http://dx.doi.org/10.1097/00006842-199909000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Potokar, John, and David Nutt. "Psychopharmacology." Current Opinion in Psychiatry 9, no. 1 (January 1996): 98–104. http://dx.doi.org/10.1097/00001504-199601000-00020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Scahill, Lawrence, Kathleen Koenig, Deirdre H. Carroll, and Maryellen Pachler. "Psychopharmacology." Journal of Child and Adolescent Psychiatric Nursing 20, no. 3 (August 2007): 188–90. http://dx.doi.org/10.1111/j.1744-6171.2007.00112.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

SMITH, JEAN C., WILLIAM L. COLEMAN, CATHERINE L. GRUS, and ADRIAN D. SANDLER. "PSYCHOPHARMACOLOGY." Journal of Developmental & Behavioral Pediatrics 17, no. 1 (February 1996): 66. http://dx.doi.org/10.1097/00004703-199602000-00023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

M, Campbell, and Cueva JE. "PSYCHOPHARMACOLOGY." Journal of Developmental & Behavioral Pediatrics 17, no. 2 (April 1996): 131. http://dx.doi.org/10.1097/00004703-199604000-00037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;, &NA;. "PSYCHOPHARMACOLOGY." Journal of Developmental & Behavioral Pediatrics 17, no. 5 (October 1996): 368–69. http://dx.doi.org/10.1097/00004703-199610000-00027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Conners, CK, CD Casat, CT Gualtieri, E. Weller, M. Reader, and A. Reiss. "PSYCHOPHARMACOLOGY." Journal of Developmental & Behavioral Pediatrics 18, no. 3 (June 1997): 212. http://dx.doi.org/10.1097/00004703-199706000-00031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

&NA;, &NA;. "PSYCHOPHARMACOLOGY." Journal of Developmental & Behavioral Pediatrics 18, no. 5 (October 1997): 358. http://dx.doi.org/10.1097/00004703-199710000-00026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

&NA;, &NA;. "PSYCHOPHARMACOLOGY." Journal of Developmental & Behavioral Pediatrics 18, no. 6 (December 1997): 433. http://dx.doi.org/10.1097/00004703-199712000-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

SANDLER, ADRIAN D. "Psychopharmacology." Journal of Developmental & Behavioral Pediatrics 23, no. 5 (October 2002): 393. http://dx.doi.org/10.1097/00004703-200210000-00029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

REIFF, MICHAEL I. "Psychopharmacology." Journal of Developmental & Behavioral Pediatrics 23, no. 5 (October 2002): 393. http://dx.doi.org/10.1097/00004703-200210000-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

SANDLER, ADRIAN D. "Psychopharmacology." Journal of Developmental & Behavioral Pediatrics 23, no. 5 (October 2002): 393–94. http://dx.doi.org/10.1097/00004703-200210000-00031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Shulman, Stanford T. "Psychopharmacology." Pediatric Annals 36, no. 9 (September 1, 2007): 527–28. http://dx.doi.org/10.3928/0090-4481-20070901-01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

&NA;. "Psychopharmacology." International Clinical Psychopharmacology 5, no. 2 (April 1990): 161–62. http://dx.doi.org/10.1097/00004850-199004000-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 1, no. 1 (February 1989): 75–78. http://dx.doi.org/10.1176/jnp.1.1.75.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 1, no. 2 (May 1989): 210–12. http://dx.doi.org/10.1176/jnp.1.2.210.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 1, no. 3 (August 1989): 324–26. http://dx.doi.org/10.1176/jnp.1.3.324.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 1, no. 4 (November 1989): 435–37. http://dx.doi.org/10.1176/jnp.1.4.435.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 2, no. 1 (February 1990): 106–7. http://dx.doi.org/10.1176/jnp.2.1.106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 2, no. 2 (May 1990): 230–31. http://dx.doi.org/10.1176/jnp.2.2.230.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 2, no. 3 (August 1990): 342–43. http://dx.doi.org/10.1176/jnp.2.3.342.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 2, no. 4 (November 1990): 457–58. http://dx.doi.org/10.1176/jnp.2.4.457.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Thronson, L. Renata, and Genevieve L. Pagalilauan. "Psychopharmacology." Medical Clinics of North America 98, no. 5 (September 2014): 927–58. http://dx.doi.org/10.1016/j.mcna.2014.06.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Minchin, M. C. W. "Psychopharmacology." Neuropharmacology 25, no. 1 (January 1986): 109. http://dx.doi.org/10.1016/0028-3908(86)90066-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 3, no. 1 (February 1991): 108–10. http://dx.doi.org/10.1176/jnp.3.1.108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 3, no. 2 (May 1991): 223–24. http://dx.doi.org/10.1176/jnp.3.2.223.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 3, no. 3 (August 1991): 341–42. http://dx.doi.org/10.1176/jnp.3.3.341.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 3, no. 4 (November 1991): 447–48. http://dx.doi.org/10.1176/jnp.3.4.447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 4, no. 1 (February 1992): 103–4. http://dx.doi.org/10.1176/jnp.4.1.103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 4, no. 2 (May 1992): 220–21. http://dx.doi.org/10.1176/jnp.4.2.220.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Silver, Jonathan M. "Psychopharmacology." Journal of Neuropsychiatry and Clinical Neurosciences 4, no. 3 (August 1992): 339–40. http://dx.doi.org/10.1176/jnp.4.3.339.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Hammersley, Diane. "Psychopharmacology." Counselling Psychology Review 35, no. 1 (June 2020): 29–32. http://dx.doi.org/10.53841/bpscpr.2020.35.1.29.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Vance, Alasdair L. A. "Book Review: Child Psychopharmacology: Child Psychopharmacology." Australian & New Zealand Journal of Psychiatry 33, no. 6 (December 1999): 965. http://dx.doi.org/10.1080/0004867990437.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Lantos, Vera. "Book Review: Psychopharmacology: Evidence-Based Psychopharmacology." Canadian Journal of Psychiatry 52, no. 5 (May 2007): 333–34. http://dx.doi.org/10.1177/070674370705200509.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

REMINGTON, GARY. "Psychopharmacology of Antipsychotics Psychopharmacology of Antidepressants." American Journal of Psychiatry 158, no. 9 (September 2001): 1538. http://dx.doi.org/10.1176/appi.ajp.158.9.1538.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Glick, Ira D. "Improving Efficiency and Effectiveness of Psychopharmacology Practice: What Must Be Done and What Shouldn't Be Done." Psychiatric Annals 53, no. 7 (July 2023): 294–97. http://dx.doi.org/10.3928/00485713-20230614-01.

Full text

Abstract:

As the science and the data underlying psychopharmacology treatments has become roughly equal to the science underlying medical illness, the level of quality care to achieve psychopharmacology clinical competence in practice has become more difficult for clinicians. This article aims to fill the gap in teaching psychopharmacology and raise the quality level by describing the core tasks for prescribing quality clinical psychopharmacology. We describe reasons why the quality is low, the most common clinical practices that are not being done, and most importantly, delineate the necessary elements for initial and ongoing follow-up visits. The goal is an integrated approach incorporating objective, subjective, and relational factors in psychopharmacology practice. [ Psychiatr Ann . 2023;53(7):294–297.]

APA, Harvard, Vancouver, ISO, and other styles

41

Jobson, K. "International Psychopharmacology Algorithm Project: Algorithms in Psychopharmacology." International Journal of Psychiatry in Clinical Practice 1, sup1 (January 1997): S3. http://dx.doi.org/10.3109/13651509709024748.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Stimmel, Glen L. "Book Review: Psychopharmacology: Part 1: Preclinical Psychopharmacology." Drug Intelligence & Clinical Pharmacy 19, no. 2 (February 1985): 153. http://dx.doi.org/10.1177/106002808501900217.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Calhoun, Laura. "Book Review: Psychopharmacology: Handbook of Female Psychopharmacology." Canadian Journal of Psychiatry 50, no. 3 (March 2005): 180–81. http://dx.doi.org/10.1177/070674370505000310.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Braslow, Joel T., and Stephen R. Marder. "History of Psychopharmacology." Annual Review of Clinical Psychology 15, no. 1 (May 7, 2019): 25–50. http://dx.doi.org/10.1146/annurev-clinpsy-050718-095514.

Full text

Abstract:

We live in an age of psychopharmacology. One in six persons currently takes a psychotropic drug. These drugs have profoundly shaped our scientific and cultural understanding of psychiatric disease. By way of a historical review, we try to make sense of psychiatry's dependency on psychiatric drugs in the care of patients. Modern psychopharmacology began in 1950 with the synthesis of chlorpromazine. Over the course of the next 50 years, the psychiatric understanding and treatment of mental illness radically changed. Psychotropic drugs played a major part in these changes as state hospitals closed and psychotherapy gave way to drug prescriptions. Our review suggests that the success of psychopharmacology was not the consequence of increasingly more effective drugs for discrete psychiatric diseases. Instead, a complex mix of political economic realities, pharmaceutical marketing, basic science advances, and changes in the mental health-care system have led to our current infatuation with psychopharmacology.

APA, Harvard, Vancouver, ISO, and other styles

45

Ebert, Michael H. "Essential Psychopharmacology." Journal of Clinical Psychiatry 59, no. 5 (May 15, 1998): 258. http://dx.doi.org/10.4088/jcp.v59n0510a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Kwentus, Joseph A. "Geriatric Psychopharmacology." Journal of Clinical Psychiatry 59, no. 11 (November 15, 1998): 625–26. http://dx.doi.org/10.4088/jcp.v59n1110b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Swann, Alan C. "Adaptive Psychopharmacology." Psychiatric Annals 35, no. 10 (October 1, 2005): 831–38. http://dx.doi.org/10.3928/00485713-20051001-08.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

McLean, Alvin, Diana D. Cardenas, Jodie K. Haselkorn, and Michael Peters. "Cognitive Psychopharmacology." NeuroRehabilitation 3, no. 2 (June 15, 1993): 1–14. http://dx.doi.org/10.3233/nre-1993-3203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Gaumer, Carol Blakely. "Psychopharmacology Handbook." Journal of Psychosocial Nursing and Mental Health Services 34, no. 9 (September 1996): 53. http://dx.doi.org/10.3928/0279-3695-19960901-24.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Nazeer, Ahsan. "Pediatric Psychopharmacology." Psychiatric Annals 51, no. 10 (October 2021): 447–48. http://dx.doi.org/10.3928/00485713-20210910-01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!